8-K
filed February 20, 2026, 6:59 PM ET
ticker ATOS
CIK 0001488039
other material
confidence high
sentiment neutral
materiality 0.50
Atossa enters $50M ATM equity offering with Rodman & Renshaw; terminates Jefferies facility
ATOSSA THERAPEUTICS, INC.
- ATM agreement allows up to $50M in common stock sales; company pays 3% commission to sales agent.
- Proceeds intended for clinical development, working capital, and general corporate purposes.
- Prior Jefferies ATM agreement terminated with no sales made; no termination penalties incurred.
- Company not obligated to sell any shares; may suspend or terminate the arrangement at any time.
- Offering registered under effective S-3 shelf (filed May 2024); prospectus supplement filed Feb 20, 2026.
Key facts
Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ATOSSA THERAPEUTICS, INC. terminated Prior Agreement with Jefferies LLC (effective 2026-02-19).
- Action
- termination
- Agreement
- atm program
- Counterparty
- Jefferies LLC
- Effective
- 2026-02-19
Exact text from the filing
On February 19, 2026, the Company delivered written notice to Jefferies LLC indicating that it is terminating the Open Market Sale Agreement SM (the “Prior Agreement”) by and between the Company and Jefferies LLC, dated November 19, 2024, effective as of February 19, 2026.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ATOSSA THERAPEUTICS, INC. entered into Sales Agreement with Rodman & Renshaw LLC valued at up to $50,000,000 (effective 2026-02-20).
- Action
- entry
- Agreement
- atm program
- Counterparty
- Rodman & Renshaw LLC
- Value
- up to $50,000,000
- Effective
- 2026-02-20
Exact text from the filing
On February 20, 2026, Atossa Therapeutics, Inc. (the “Company”) entered into the At the Market Offering Agreement, dated February 20, 2026 (the “Sales Agreement”), with Rodman & Renshaw LLC (the “Sales Agent”), pursuant to which the Company may offer and sell from time to time up to $50,000,000 of shares of the Company’s common stock
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.